{"filing":{"accession_number":"0001178913-26-003296","cik":"0001553846","ticker":"RDHL","company_name":"RedHill Biopharma Ltd.","form":"6-K","filing_date":"2026-06-22","report_date":null,"primary_document":"zk2635593.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1553846/000117891326003296/zk2635593.htm"},"events":[{"id":12792,"run_id":11351,"accession_number":"0001178913-26-003296","anchor_item_number":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"RedHill Biopharma announced the closing of a private placement of 8,571,429 ADSs at $0.70 per ADS with accompanying warrants, generating $6 million upfront with up to $13.4 million in potential proceeds from warrant exercises. This is an unregistered equity issuance under Section 4(a)(2) and Regulation D, representing a dilutive capital raise typical of small- and mid-cap biopharmaceutical companies. The company explicitly notes the securities \"have not been registered under the Securities Act\" and references a registration rights agreement for future resale registration, confirming the private placement structure.","company_name":"RedHill Biopharma Ltd.","ticker":"RDHL","filing_date":"2026-06-22","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":9744,"accession_number":"0001178913-26-003296","item_number":null,"item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"RedHill Biopharma announced the closing of a private placement of 8,571,429 ADSs at $0.70 per ADS with accompanying warrants, generating $6 million upfront with up to $13.4 million in potential proceeds from warrant exercises. This is an unregistered equity issuance under Section 4(a)(2) and Regulation D, representing a dilutive capital raise typical of small- and mid-cap biopharmaceutical companies. The company explicitly notes the securities \"have not been registered under the Securities Act\" and references a registration rights agreement for future resale registration, confirming the private placement structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T20:52:46.512347+00:00","company_name":"RedHill Biopharma Ltd.","ticker":"RDHL","filing_date":"2026-06-22"}]}